SE392616B - Forfarande for framstellning av kinazolinonforeningar - Google Patents

Forfarande for framstellning av kinazolinonforeningar

Info

Publication number
SE392616B
SE392616B SE739172A SE739172A SE392616B SE 392616 B SE392616 B SE 392616B SE 739172 A SE739172 A SE 739172A SE 739172 A SE739172 A SE 739172A SE 392616 B SE392616 B SE 392616B
Authority
SE
Sweden
Prior art keywords
kinazolinone
compounds
procedure
preparation
kinazolinone compounds
Prior art date
Application number
SE739172A
Other languages
English (en)
Swedish (sv)
Inventor
K Ishizumi
K Mori
M Yamamoto
M Koshiba
S Inaba
H Yamamoto
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4781271A external-priority patent/JPS50670B1/ja
Priority claimed from JP4839771A external-priority patent/JPS4929195B1/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE392616B publication Critical patent/SE392616B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
SE739172A 1971-06-29 1972-06-06 Forfarande for framstellning av kinazolinonforeningar SE392616B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4781271A JPS50670B1 (cg-RX-API-DMAC7.html) 1971-06-29 1971-06-29
JP4839771A JPS4929195B1 (cg-RX-API-DMAC7.html) 1971-06-30 1971-06-30

Publications (1)

Publication Number Publication Date
SE392616B true SE392616B (sv) 1977-04-04

Family

ID=26387992

Family Applications (1)

Application Number Title Priority Date Filing Date
SE739172A SE392616B (sv) 1971-06-29 1972-06-06 Forfarande for framstellning av kinazolinonforeningar

Country Status (5)

Country Link
CA (1) CA956636A (cg-RX-API-DMAC7.html)
CH (1) CH574940A5 (cg-RX-API-DMAC7.html)
DK (1) DK132624C (cg-RX-API-DMAC7.html)
NL (1) NL7209078A (cg-RX-API-DMAC7.html)
SE (1) SE392616B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631283A (en) * 1982-09-30 1986-12-23 Ortho Pharmaceutical Corporation Ortho substituted dihydroxy-2(1H)quinazolinone-1-alkanoic acids
US4490374A (en) * 1982-09-30 1984-12-25 Ortho Pharmaceutical Corporation 5,6-Dialkoxy-3,4-optionally substituted-2(1H)quinazolinones, composition and method of use

Also Published As

Publication number Publication date
CA956636A (en) 1974-10-22
DK132624C (da) 1976-06-28
DK132624B (da) 1976-01-12
CH574940A5 (en) 1976-04-30
NL7209078A (cg-RX-API-DMAC7.html) 1973-01-03

Similar Documents

Publication Publication Date Title
SE385891B (sv) Forfarande for framstellning av bensopyranforeningar
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE417969B (sv) Forfarande for framstellning av 3-metylencefalosporinforeningar
SE390633B (sv) Forfarande for framstellning av ethambutol
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE393615B (sv) Forfarande for framstellning av 6-metyl-8 beta-ureidometyl-ergolener
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE412756B (sv) Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar
SE387948B (sv) Forfarande for framstellning av tiofen
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner